Current Issue

J Psychiatry Neurosci 2021 January-February;46(1)

Editorial

Why did the kitten cross the road? A meditation on positive versus negative reinforcement in addiction
M. Leyton

Review Paper

Precision clinical trials: a framework for getting to precision medicine for neurobehavioural disorders
E.J. Lenze, G.E. Nicol, D.L. Barbour, T. Kannampallil, A.W.K. Wong, J. Piccirillo, A.T. Drysdale, C.M. Sylvester, R. Haddad, J.P. Miller, C.A. Low, S.N. Lenze, K.E. Freedland, T.L. Rodebaugh

Research Papers

Metabotropic glutamate type 5 receptor binding availability during dextroamphetamine sensitization in mice and humans
K. Smart, A. Nagano-Saito, M.S. Milella, D.Y. Sakae, M. Favier, E. Vigneault, L. Louie, A. Hamilton, S.S.G. Ferguson, P. Rosa-Neto, S. Narayanan, S. El Mestikawy, M. Leyton, C. Benkelfat
[Appendix]

Noninvasive brain stimulation in children and adults with attention-deficit/hyperactivity disorder: a systematic review and meta-analysis
S.J. Westwood, J. Radua, K. Rubia
[Appendix]

Uncovering neurodevelopmental paths to autism spectrum disorder through an integrated analysis of developmental measures and neural sensitivity to faces
G. Bussu, A. Llera, E.J.H. Jones, C. Tye, T. Charman, M.H. Johnson, C.F. Beckmann, J.K. Buitelaar
[Appendix]

G-protein coupled receptor 88 knockdown in the associative striatum reduces psychiatric symptoms in a translational male rat model of Parkinson disease
B. Galet, M. Ingallinesi, J. Pegon, A.D. Thi, P. Ravassard, N.F. Biguet, R. Meloni
[Appendix]

Emotional and interpersonal mechanisms in community SSRI treatment of social anxiety disorder
L.M. Rappaport, M.D. Hunter, J.J. Russell, G. Pinard, P. Bleau, D.S. Moskowitz
[Appendix]

Confidence in visual motion discrimination is preserved in individuals with schizophrenia
N. Faivre, M. Roger, M. Pereira, V. de Gardelle,  J-C. Vergnaud, C. Passerieux, P. Roux
[Appendix]

Greater decision uncertainty characterizes a transdiagnostic patient sample during approach-avoidance conflict: a computational modelling approach
R. Smith, N. Kirlic, J.L. Stewart, J. Touthang, R. Kuplicki, S. Khalsa, J. Feinstein, M.P. Paulus, R. Aupperle
[Appendix 1 | Appendix 2 | Appendix 3]

Cortical inhibition, facilitation and plasticity in late-life depression: effects of venlafaxine pharmacotherapy
J.I. Lissemore, B.H. Mulsant, T.K. Rajji, J.F. Karp, C.F. Reynolds III, E.J. Lenze, J. Downar, R. Chen, Z.J. Daskalakis, D.M. Blumberger
[Appendix]

Efficacy of single-session transcranial direct current stimulation on addiction-related inhibitory control and craving: a randomized trial in males with Internet gaming disorder
L-l. Wu, M.N. Potenza, N. Zhou, H. Kober, X-h. Shi, S.W. Yip, J-h. Xu, L. Zhu, R. Wang, G-q. Liu, J-t. Zhang
[Appendix]

Suicide risk within 1 year of dementia diagnosis in older adults: a nationwide retrospective cohort study
J.W. Choi, K.S. Lee, E. Han
[Appendix]

A voxel-wise meta-analysis of task-based functional MRI studies on impaired gain and loss processing in adults with addiction
Z. Qiu, J. Wang
[Appendix]

11β-Hydroxylase (CYP11B1) gene variants and new-onset depression in later life
M. Ancelin, J. Norton, K. Ritchie, I. Chaudieu, J. Ryan
[Appendix]

DCC gene network in the prefrontal cortex is associated with total brain volume in childhood
A. Morgunova, I. Pokhvisneva, S. Nolvi, S. Entringer, P. Wadhwa, J. Gilmore, M. Styner, C. Buss, R.B. Sassi, G.B.C. Hall, K.J. O’Donnell, M.J. Meaney, P.P. Silveira, C.A. Flores

The role of anthranilic acid in the increase of depressive symptoms and major depressive disorder during treatment for hepatitis C with pegylated interferon-α2a and oral ribavirin
T. Pawlowski, D. Pawlak, M. Inglot, M. Zalewska, D. Marciniak, J. Bugajska,
J. Janocha-Litwin, K. Malyszczak

Association between depressive symptoms and pulse wave velocity is mediated by increased adiposity in older adults with type 2 diabetes
M. C. Moh, S. Low, T. P. Ng, S. F. Ang, K. Ang, C. F. Sum, T. Subramaniam, S. C. Lim
[Appendix]

Effects of childhood adversity on the volumes of the amygdala subnuclei and hippocampal subfields in individuals with major depressive disorder
A. Aghamohammadi-Sereshki, N. J. Coupland, P. H. Silverstone, Y. Huang, K. M. Hegadoren, R. Carter, P. Seres, N. V. Malykhin
[Appendix]

Therapeutic benefits of pharmacologic and nonpharmacologic treatments for depressive symptoms after traumatic brain injury: a systematic review and network meta-analysis
Y.-S. Cheng, P.-T. Tseng, Y.-C. Wu, Y.-K. Tu, C.-K. Wu, C.-W. Hsu, W.-T. Lei, D.-J. Li, T.-Y. Chen, B. Stubbs, A. F. Carvalho, C.-S. Liang, T.-C. Yeh, C.-S. Chu, Y.-W. Chen, P.-Y. Lin, M.-K. Wu, C.-K. Sun
[Appendix]

Psychopharmacology for the Clinician

The antipsychotic potential of cannabidiol: clinical implications for patients with psychosis and comorbid cannabis use disorder
N. Garel, K.T. Greenway, R. Joober